Impact of the therapeutic positioning report in the P&R process in Spain: analysis of orphan drugs approved by the European Commission and reimbursed in Spain from 2003 to 2019

BACKGROUND: Pricing and reimbursement decisions for orphan drugs are faced with differences access between European countries depending on each reimbursement policies, evaluation processes and timings. In 2013, the therapeutic positioning report was introduced in the pricing and reimbursement proces...

Descripción completa

Detalles Bibliográficos
Autores principales: Badia, Xavier, Vico, Tania, Shepherd, John, Gil, Alicia, Poveda-Andrés, José Luis, Hernández, César
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456380/
https://www.ncbi.nlm.nih.gov/pubmed/32859228
http://dx.doi.org/10.1186/s13023-020-01507-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7456380/
https://www.ncbi.nlm.nih.gov/pubmed/32859228
http://dx.doi.org/10.1186/s13023-020-01507-4

Ejemplares similares